NUCLEOLIN and cancer: A family of drugs targeting the nucleolin protein are being developed for cancer therapy; these AGRO100 drugs (named for Guanine-Rich Oligonucleotides) reportedly acted against cultured cell lines from several different cancers and successfully stabilized disease in six of nine patients in phase I clinical trials.